Back to Search
DR. MICHAEL BOUVET M.D.
M.D.
Surgical Oncology Physician
NPI: 1033177803IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgery Physician
Surgery
Code: 208600000X
G69035(CA)
Surgical Oncology PhysicianPrimary
Surgery — Surgical Oncology
Code: 2086X0206X
G69035(CA)
Education
UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE
Class of 1989
Research & Publications (20)
In vivo color-coded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases.
PMID 17145875·Cancer Res·2006
7-preclinical
High correlation of whole-body red fluorescent protein imaging and magnetic resonance imaging on an orthotopic model of pancreatic cancer.
PMID 16267005·Cancer Res·2005
4-observational
Parathyroid hormone-related protein as a novel tumor marker in pancreatic adenocarcinoma.
PMID 11893937·Pancreas·2002
7-preclinical
Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model.
PMID 11888932·Cancer Res·2002
7-preclinical
Human pancreatic adenocarcinomas express parathyroid hormone-related protein.
PMID 11232017·J Clin Endocrinol Metab·2001
8-other
Chronologically-specific metastatic targeting of human pancreatic tumors in orthotopic models.
PMID 11315094·Clin Exp Metastasis·2000
7-preclinical
Factors influencing survival after resection for periampullary neoplasms.
PMID 11036132·Am J Surg·2000
8-other
A quinhydrone-type 2 ratio 1 acceptor-donor charge transfer complex obtained via a solvent-free reaction.
PMID 16609793·Chem Commun (Camb)·2006
8-other
Upregulation of thrombospondin-1 and angiogenesis in an aggressive human pancreatic cancer cell line selected for high metastasis.
PMID 19584238·Mol Cancer Ther·2009
7-preclinical
Lentivirus-based DsRed-2-transfected pancreatic cancer cells for deep in vivo imaging of metastatic disease.
PMID 19589544·J Surg Res·2009
7-preclinical
Complementarity of ultrasound and fluorescence imaging in an orthotopic mouse model of pancreatic cancer.
PMID 19351417·BMC Cancer·2009
4-observational
Efficacy of a genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice.
PMID 19528442·Anticancer Res·2009
7-preclinical
A color-coded orthotopic nude-mouse treatment model of brain-metastatic paralyzing spinal cord cancer that induces angiogenesis and neurogenesis.
PMID 19143765·Cell Prolif·2009
7-preclinical
Development of the transgenic cyan fluorescent protein (CFP)-expressing nude mouse for "Technicolor" cancer imaging.
PMID 19306297·J Cell Biochem·2009
7-preclinical
Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain of Salmonella typhimurium.
PMID 19221501·Cell Cycle·2009
7-preclinical
Fluorescent LYVE-1 antibody to image dynamically lymphatic trafficking of cancer cells in vivo.
PMID 18599080·J Surg Res·2009
7-preclinical
A transgenic red fluorescent protein-expressing nude mouse for color-coded imaging of the tumor microenvironment.
PMID 19097136·J Cell Biochem·2009
7-preclinical
Flaviviral methyltransferase/RNA interaction: structural basis for enzyme inhibition.
PMID 19501254·Antiviral Res·2009
8-other
The cyan fluorescent protein (CFP) transgenic mouse as a model for imaging pancreatic exocrine cells.
PMID 19287108·JOP·2009
7-preclinical
Imaging of primary and metastatic pancreatic cancer using a fluorophore-conjugated anti-CA19-9 antibody for surgical navigation.
PMID 18264829·World J Surg·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 3855 HEALTH SCIENCES DR
LA JOLLA, CA 92093 - Phone
- (800) 926-8273
Quick Facts
- NPI
- 1033177803
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 3
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile